BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33371107)

  • 21. Corticosteroids for myasthenia gravis.
    Schneider-Gold C; Gajdos P; Toyka KV; Hohlfeld RR
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002828. PubMed ID: 15846640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ephedrine treatment for autoimmune myasthenia gravis.
    Lipka AF; Vrinten C; van Zwet EW; Schimmel KJ; Cornel MC; Kuijpers MR; Hekster YA; Weinreich SS; Verschuuren JJ
    Neuromuscul Disord; 2017 Mar; 27(3):259-265. PubMed ID: 28007405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina: A randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Sun YL; Yao YL; Jia MJ; Sun YY; Li HL; Ruan XF; Wang XL
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116959. PubMed ID: 37487965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
    Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
    Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholinesterase inhibitor treatment for myasthenia gravis.
    Mehndiratta MM; Pandey S; Kuntzer T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006986. PubMed ID: 21328290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma exchange for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2002; 2002(4):CD002275. PubMed ID: 12519572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial.
    He J; Li Z; Huang W; Guan W; Ma H; Yang ZF; Wang X
    BMJ Open; 2019 Apr; 9(4):e024800. PubMed ID: 30944133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Tian Y; Zhang J; Zhao Y; Mao J; Zhu L; Gao R; Wang X; Zhu M; Ma L; Zhao M; Zheng W
    Trials; 2018 Oct; 19(1):577. PubMed ID: 30342551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial.
    He H; Chen G; Gao J; Liu Y; Zhang C; Liu C; Li H; He Q; Li J; Wang J
    Trials; 2018 Sep; 19(1):515. PubMed ID: 30241562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
    Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial.
    Zhang S; Zhao L; Wang H; Wang C; Huang S; Shen H; Wei W; Tao L; Zhou T
    BMC Complement Altern Med; 2013 Mar; 13():54. PubMed ID: 23453018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.
    Deng D; Chen Z; Jia L; Bu J; Ye M; Sun L; Gen Y; Zhang W; Chen G; Fang B
    Trials; 2019 Dec; 20(1):817. PubMed ID: 31888702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
    Zu Y; Li D; Lei X; Zhang H
    Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized group sequential comparative trial.
    Wu H; Jing Z; Tang X; Wang X; Zhang S; Yu Y; Wang Z; Cao H; Huang L; Yu Y; Wang Y
    BMC Gastroenterol; 2011 Jul; 11():81. PubMed ID: 21762493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional Chinese medicine Shenqi compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: Study protocol for a randomized controlled multicenter trial.
    Zhu Q; Kang J; Xu G; Li J; Zhou H; Liu Y
    Medicine (Baltimore); 2020 Mar; 99(11):e19501. PubMed ID: 32176092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
    Pasnoor M; He J; Herbelin L; Burns TM; Nations S; Bril V; Wang AK; Elsheikh BH; Kissel JT; Saperstein D; Shaibani JA; Jackson C; Swenson A; Howard JF; Goyal N; David W; Wicklund M; Pulley M; Becker M; Mozaffar T; Benatar M; Pazcuzzi R; Simpson E; Rosenfeld J; Dimachkie MM; Statland JM; Barohn RJ;
    Neurology; 2016 Jul; 87(1):57-64. PubMed ID: 27306628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
    Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
    Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis.
    Wu H; Wang Z; Xi J; Liu J; Yan C; Song J; Wang L; Jing S; Wang Y; Zhao C
    Eur Neurol; 2020; 83(5):500-507. PubMed ID: 32932253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.